FDA Approved: * September 28, 2015
Pharm Company: * PAR PHARM
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Pimozide Overview

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the Q...

Read more Pimozide Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pimozide

Recent Pimozide Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 1mg, 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Pimozide: (3 results)

Sorted by National Drug Code
  • 49884-347 Pimozide 1 mg Oral Tablet by Par Pharmaceutical Companies, Inc.
  • 49884-348 Pimozide 2 mg Oral Tablet by Par Pharmaceutical Companies, Inc.
  • 69189-0462 Pimozide 2 mg Oral Tablet by Avera Mckennan Hospital

Other drugs which contain Pimozide or a similar ingredient: (1 result)